RECURRENT
Clinical trials for RECURRENT explained in plain language.
Never miss a new study
Get alerted when new RECURRENT trials appear
Sign up with your email to follow new studies for RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR t cell therapy takes on Hard-to-Treat ovarian cancer
Disease control Recruiting nowThis early-phase trial is testing a new treatment for ovarian cancer that has returned after standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. The main goal is to find a safe dose and see what side…
Matched conditions: RECURRENT
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug cocktail aims to outsmart ALK lung cancer
Disease control Recruiting nowThis study tests a combination of two drugs—lorlatinib (a daily pill) and ramucirumab (an IV infusion every three weeks)—in people with advanced ALK-rearranged non-small cell lung cancer. The first part finds the safest dose, and the second part checks if that dose helps keep the…
Matched conditions: RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Engineered immune cells take on recurrent head and neck cancer
Disease control Recruiting nowThis study tests a new treatment called iC9-CAR.CSPG4 T cells for people with head and neck cancer that has come back after standard treatments. The therapy uses a patient's own immune cells, modified in a lab to better recognize and attack cancer cells. The main goals are to fin…
Matched conditions: RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a workout after cancer treatment help you live longer?
Knowledge-focused Recruiting nowThis study looks at whether exercise after finishing cancer treatment is linked to better outcomes, like longer survival without the cancer coming back. Researchers will analyze data from 1,000 adult cancer survivors at Memorial Sloan Kettering. The goal is to see if those who ex…
Matched conditions: RECURRENT
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New study aims to find best treatments for limited cervical cancer spread
Knowledge-focused Recruiting nowThis study looks back at medical records of 350 people with cervical cancer that has come back or spread to a few spots. The goal is to see how well treatments like radiation or surgery work, alone or with chemotherapy. Researchers want to find out which patients benefit most fro…
Matched conditions: RECURRENT
Sponsor: Tata Memorial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC